objective To compare WHO's traditional (1997) and revised (2009) guidelines for dengue classification, using a large sample of patients of all ages with varying clinical conditions from a dengue-endemic area in Brazil.
Introduction
Dengue is the most important arboviral disease in humans [1] , caused by the dengue virus (DENV) and transmitted by bites from female mosquitoes of the Aedes spp. Endemic in most tropical and subtropical areas [2] , more than half the world's population is at risk of infection [3] . Approximately, 40-75% of dengue cases in the Americas occur in Brazil [4] .
Dengue virus is a single-stranded positive-sense RNA virus belonging to the family Flaviviridae and genus Flavivirus, that can cause asymptomatic or even fatal infection by its four serotypes (DENV-1-4). Estimates suggest that while~75% of infections are asymptomatic, onlỹ 5% progress to severe illness [2] . This may vary by age, dengue incidence, and by regional epidemiology [5, 6] . Typically, the diagnosis of dengue is based on the detection of non-structural protein (NS1) antigen and anti-DENV antibodies (IgG/IgM) in the blood, and viral nucleic acids using polymerase chain reaction (PCR), although the latter is used less frequently in clinical management [7] . There is no specific treatment or effective vaccine against dengue [8] . Furthermore, there is a lack of specific and reliable early warning signs for severe dengue (SD) [1] . Therefore, an adequate classification of dengue may be an important tool to improve treatment and clinical management of dengue cases, both in hospitalised and ambulatory settings [8] .
Dengue is classified according to clinical manifestations, from a self-limiting syndrome to dengue haemorrhagic fever (DHF) [9] . The traditional WHO classification of 1997 categorises the disease as dengue fever (DF) (classical dengue) and DHF; the latter being divided into four classes, of which, classes III and IV are called dengue shock syndrome (DSS). In DF, the individual may present with high acute fever and two or more of the following manifestations: headache, retro-orbital pain, myalgia, arthralgia, rash, haemorrhage and leukopenia. In DHF, patients must present with fever or history of acute fever lasting 2-7 days and at least one of the following haemorrhagic manifestations: positive tourniquet test, petechiae, ecchymosis or purpura, mucosal bleeding, and haematemesis or melena. These patients must also present with thrombocytopenia (≤100 000 cells/mm 3 ) and evidence of plasma leakage due to increased vascular permeability. In patients with DSS, all criteria for DHF should be present, in addition to evidence of circulatory failure [10] .
As a result of changes in the epidemiology of dengue, the emergence of new patterns of disease, and increasing clinical research, limitations of the WHO 1997 guidelines for dengue classification became apparent [11, 12] . There was dissatisfaction with the traditional classification of dengue, mainly due to the low sensitivity for the detection of more SD cases and thus WHO presented revised guidelines in 2009. In these new guidelines, dengue disease was categorised as Dengue with or without Warning Signs and SD. Patients with dengue without warning signs (DWSÀ) are those who live in or have travelled to a dengue-endemic area and have fever, along with at least two of the following symptoms: nausea, vomiting, rash, aches and pains, leucopenia, and positive tourniquet test. To be considered as dengue with warning signs (DWS+), patients must present with the previous criteria, in addition to any of the following symptoms: abdominal pain or tenderness, persistent vomiting, clinical fluid accumulation, mucosal bleeding, lethargy, restlessness, liver enlargement >2 cm, and increase in haematocrit concurrent with rapid decrease in platelet count. Severe dengue is characterised by at least one of the following criteria: severe plasma leakage leading to shock and/or fluid accumulation with respiratory distress, severe bleeding as evaluated by clinician, severe organ involvement (liver: alanine amino transferase or aspartate amino transferase ≥1000 IU/l; central nervous system: impaired consciousness; and failure of heart and other organs) [1] .
The comparability between studies conducted over time and across countries is affected by differing guidelines. Several studies have also highlighted a lack of agreement between the 1997 and 2009 WHO guidelines, and criticised guidelines for failing to provide a categorisation that would help improve treatment and clinical management. Previous studies, however, have used relatively small sample sizes, and many have included only paediatric or hospitalised patients [13] [14] [15] .
In this study, we fill a gap in the literature by using a large sample of patients of all ages with varying clinical conditions from a dengue-endemic area in an inland city in Brazil, to compare WHO's traditional (1997) and revised (2009) guidelines for dengue classification. Specifically, we: (i) evaluate predictors of dengue severity, including dengue signs and symptoms and patient demographics as explanatory variables, and (ii) compare the degree of agreement between the guidelines. We hope these results will help inform the debate about potential improvements in dengue classification guidelines.
Materials and methods
This retrospective study included 30 670 dengue cases registered (in public and private health services) in the city of São Jos e do Rio Preto, São Paulo, Brazil, and notified to the Brazilian Ministry of Health in 1998-2012 (there were 7 313 164 reported cases in Brazil during that same period) [16] . São Jos e do Rio Preto is a municipality of around 400 000 people, situated inland 440 km north-west of São Paulo. Clinical suspicion of dengue was confirmed by IgM enzyme-linked, immunosorbent assay (ELISA), detection of NS1, or by polymerase chain reaction.
We classified 30 670 dengue patients by disease severity following both guidelines and estimated the main factors associated with severity using stereotype ordinal logistic regressions. We used signs and symptoms related to symptomatic DENV infection and other routine demographic variables, such as patients' age and sex, as explanatory variables.
We defined ordinal outcome variables following the 1997 (1 = DF; 2 = DHF; 3 = DSS, reference category) and 2009 guidelines (1 = Dengue without Warning Sings; 2 = DWS+; 3 = SD, reference category). DHF was attributed only to individuals with grades I and II in our study for the purpose of statistical analysis [1, 10] . Our model included the following dichotomous explanatory variables in each group: sex (1 = female; 0 = male), ethnicity (1 = white; 0 = not white), age (0-15 years = 1; >15 years = 0), schooling (>4 year of study = 1; ≤4 year of study = 0), locality (1 = urban; 0 = rural), previous dengue (confirmed via IgG test and reported by subject; 1 = seropositive; 0 = seronegative), and the following symptoms (1 = present; 0 = absent): fever, headache, retro-ocular pain, prostration, myalgia, arthralgia, nausea or vomiting, diarrhoea, and haemorrhagic manifestations (epistaxis, petechiae, exanthema, haematuria, tourniquet test, metrorrhagia, bleeding gums, gastrointestinal bleeding), plasma leakage (ascites, pleural leakage, haemoconcentration), hypotensive shock (systolic pressure <90 mmHg), hepatomegaly, and organic dysfunction (myocarditis, liver failure, neurological manifestations).
Stereotype ordinal logistic regression models are not commonly used in public health studies [17] . Previous studies examining the guidelines have usually analysed data using dichotomous specification; however, both dengue guidelines have suggested using naturally ordinal variables with three levels [9, 18, 19] . We used stereotype models to allow the magnitude of each coefficient to vary across the categories of dengue illness, instead of, for example, assuming proportional odds. Using dengue severity in ordinal form allowed as to avoid unnecessary loss of information from each category [17] .
We ran stereotype ordinal logistic models, with the 1997 and 2009 classifications as outcome variables, and all clinical symptoms and risk factors for severity as explanatory variables in our final model. We report adjusted odds ratios with 95% confidence intervals (CI), and assessed the fit of our models using deviance tests, with P > 0.05 suggesting good adjustment.
As a robustness check, we tested dependence between the explanatory and outcome variables for the 1997 and 2009 classifications using the Kolmogorov-Smirnov independence test (with P < 0.05). Subsequently, we determined the level of agreement between the explanatory and outcome variables in both WHO classifications based on Cramer's V test. Last, we used Kendall's tau-b correlation coefficient to identify the degree of agreement between the two classifications for all study patients. In both Cramer's V test and Kendall's tau-b correlation, values lower than 0.2 indicate very poor agreement, between 0.2 and 0.4 indicate slight agreement, 0.4 and 0.6 indicates moderate agreement, 0.6 and 0.8 indicates substantial (good or high) agreement, and values greater than 0.8 indicate excellent or almost perfect agreement [20] . We performed multivariate regressions using R (version 3.3.3, VGAM package, rrvglm function; The R Project for Statistical Computing, Vienna, Austria); statistical tests were performed using SPSS (version 19; SPSS Inc., Chicago, IL, USA).
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Results
Nearly 25% of patients had information about treatment setting (n = 7613); of these, 834 (10.96%) were hospitalised and 6779 (89.04%) received only ambulatory care. There were 28 fatal episodes reported. Women were predominant in all dengue severity categories. Most patients were >15 years of age (mean = 37.8 years; standard deviation 18.0 years). Most patients presented general symptoms, such as fever and myalgia. In our sample, potentially serious signs and symptoms, such as bleeding or suggestive events of plasma extravasation, were rare. Table 1 shows descriptive statistics by dengue classification guidelines.
Some predictors did not generate betas in the univariate analysis, and were not included in our final model. Table 2 shows the results from the regressions for dengue severity following the 1997 WHO dengue classification guidelines. Based on WHO 1997, patients with haemorrhagic manifestations classified as DF had a 27.94 fold higher risk for progression to DHF in comparison with patients classified as DF without any haemorrhagic manifestation (Table 2 , Panel B, OR = 27.94; CI 95% = 23.42-33.33). Similar results were observed when evaluating patients who developed the most severe condition. Patients classified as DF who presented with haemorrhagic manifestations had a 7.54 fold higher risk of developing DSS, compared to patients classified as DF who did not have any haemorrhagic manifestations (OR = 7.54; CI 95% = 6.32-8.99).
In Table 3 , using WHO 2009 classification, the risk of progression to SD was only 1.55 fold higher for patients classified as DWSÀ with haemorrhagic manifestations (Table 3 , Panel B, OR = 1.55; CI 95% = 1.41-1.71) than patients classified as DWSÀ without any haemorrhagic manifestations. Using the 2009 classification, our results suggest that diarrhoea showed the highest risk of evolution from DWSÀ to SD (OR = 1.82; CI 95% = 1.59-2.09).
The Kolmogorov-Smirnov dependence test showed a dependence between most explanatory and outcome variables (P < 0.001); however, we found very poor agreement between dengue severity and most explanatory variables in our final models for both classifications (Table 4 ; Cramer's V <0.2; P < 0.001).
Hypotensive shock was the exception for both classifications, presenting dependence (Z = 56.42; P < 0.001, and Z = 55.24; P < 0.001) and high agreement (Cramers's V = 1; P < 0.001, and Cramers's V = 0.97; P < 0. (Table 4) .
We found substantial agreement between WHO 1997 and 2009 (Kendall tau-b = 0.79; P < 0.001) (Figure 1) . A similar percentage of patients were classified in the category of greatest severity in both classifications.
One percentage was classified as DSS and 17% as SD, with a considerable difference in the number of patients between the two categories (276/30 670). The lowest severity category presented the greatest difference between the patients' distribution in the two classifications: 64.9% of the patients were classified as DF in the 1997 group, while 55.6% were classified as DWSÀ in the 2009 group (Figure 1) .
Discussion
To the best of our knowledge, this is the first study comparing the WHO 1997 and 2009 dengue classification guidelines using a large sample of patients, including all ages and various levels of dengue severity. Overall, our results show that compared to 2009 guidelines, patients tended to be classified in lower severity categories when following 1997 guidelines. Dengue signs and symptoms in patients were poorly correlated to disease severity classifications as defined by WHO 1997 and 2009 guidelines. The observed distribution of dengue cases in our study showed that patients with potentially greater severity of symptoms were more accurately detected when using 2009 guidelines (Figure 1) , as has been previously observed [5, 16] . Our results also suggest that 2009 guidelines are more sensitive in the detection of severe cases than 1997 guidelines. However, the most severe cases detected by WHO 2009 can be overestimated [21] , which could result in erroneous overestimation as severe disease. Moreover, following 2009 guidelines, 27.4% (8404/ 30 670) of patients were classified as DWS+ and, of those, 90.4% (7598/8404) did not develop hypotensive shock. It is possible that these patients may have not needed hospitalisation, consistent with previous findings in the literature [9, 15, 22] . As dengue outbreaks often present substantial spatial and temporal clustering [23] , misclassifying dengue patients as severe may result in unnecessary congestion of the healthcare system [9, 24] .
Although our results suggest that some symptoms, such as haemorrhagic manifestations for WHO 1997 and 2009, and diarrhoea for WHO 2009, are correlated to a high risk of SD, it is possible that these symptoms have other causes. Previous studies suggest that some clinical complications observed in dengue patients are caused by iatrogenic factors, including difficulty in breathing from excessive treatment with intravenous fluids or due to other diseases, such as fever-related convulsions and prior hepatic failure [25, 26] .
Intriguingly, in our univariate analysis, compared to patients with less than 4 years of schooling, patients with higher schooling exhibited a higher risk of being diagnosed with DSS and DHF than with DF by WHO 1997 ( Table 2 , Panel A). This risk was marginally lower when assessing the odds of a patient being diagnosed with SD compared to DWSÀ, following WHO 2009 (Table 3 , Panel A) but higher schooling was still correlated with higher risk of severe disease. At least two mechanisms could explain this correlation. First, there may be omitted variables associated with years of education that could affect dengue severity. For example, a 2010 study conducted in two cities located in northeast Brazil found a significant association between DHF and individuals with 4-7 years of schooling (OR = 2.45, 95% CI = 1.20-4.99), as well as individuals with 8-11 years of schooling (OR = 4.67; 95% CI = 2.35-9.27) [13] . Those authors argued that individuals with white or mixed ethnicity, usually with more schooling, may be at higher risk of developing SD [19] . However, in our study, ethnicity was not significantly associated with SD (Table 3) . A second plausible mechanism relates to socioeconomic status. More schooling is often associated with higher income and thus better housing (e.g., screened windows, air conditioning). Better living conditions may result in longer periods between DENV infections, and therefore a higher likelihood of developing SD [22, 27] . Figueiredo et al. [19] suggested that other diseases may be more prevalent in individuals with higher schooling/income (e.g. and asthma) that contribute to more severe clinical manifestations. At present, we lack the data to test these hypotheses; this apparent association needs further assessment. The 2009 guidelines attempted to improve the sensitivity of detection of more severe cases compared to 1997 guidelines, which resulted in a slight disagreement between the two classifications, as shown by the Kendall's tau-b (0.79; P < 0.001), consistent with previous findings [21] . Further, our results suggest that even the 2009 guidelines should be reevaluated [26] . The low agreement observed for almost all variables in the models generated for both severity classifications suggests that dengue symptoms and risk factors alone may not be good predictors of dengue severity. The clinical variables that were added in WHO 2009, such as organ failure, may not necessarily represent a direct consequence of dengue, but of prior comorbidity or even iatrogenesis, as is the case of pulmonary distress due to hyperhydration [26] . Even classical information adopted in both classifications may not express the clinical reality in dengue patients; the tourniquet test has been shown to have a low sensitivity in dengue diagnosis [28] , and, since many DENVinfected patients could be non-febrile, fever may not be a reliable starting point criterion [29] .
Our study has at least six limitations. First, retrospective data almost always present errors in registration. We reviewed, cleaned, and debugged data on reported patients to minimise this. Second, comorbidities in dengue patients were not registered in our dataset. This limits the identification of risk factors not directly associated with dengue that may have contributed to allocation in a category of greater dengue severity.
A third limitation is the uncommon finding of a large number of patients registered as developing hypotensive shock. Hypotensive shock was defined in our dataset as the presence of systolic pressure lower than 90 mmHg; unfortunately, we have no records on volume replacement in these patients. It is possible that (i) arterial pressures below 90 mmHg were not correlated with severe clinical manifestations and/or that (ii) cases identified as shock did not represent the clinical reality, since we obtained this information directly from a no-longer used dengue notification form in Brazil.
Fourth, some variables such as prostration, nausea or vomiting, abdominal pain, thrombocytopenia, plasma leakage, hypotensive shock, hepatomegaly, and organic dysfunction did not generate the corresponding correlation coefficients (beta coefficients); thus, they could not be analysed using logistic regression. However, we evaluated the dependence (Kolmogorov-Smirnov dependence test) and strength of association (Cramer's V test) of all variables.
Fifth, the data collected for this study represent a large sample of patients with good access to quality hospital care, which may not be representative of healthcare in Brazil. The death rate (28/30 670) was substantially lower than the average in Brazil for at least two reasons [4] -the relatively good healthcare access and quality in São Jos e do Rio Preto and possibly unregistered deaths in our dataset. Finally, the data were only from Brazil. Considering that WHO guidelines are meant to be used globally, a comparison of 1997 and 2009 guidelines for dengue classification should include data from regions with varying dengue epidemiology. In fact, children are a much higher risk group in Southeast Asia compared to Latin America, where the most common clinical expression is DF in adults. Children in Southeast Asia are usually considered at higher risk for DHF/DSS/SD and, more generally, the rates of SD are substantially higher in Southeast Asia [5, 6] . In our study, children accounted for only about 10% of reported cases. These numbers are largely consistent with dengue epidemiology in Brazil, where adults have higher rates of symptomatic infection, although the age distribution seems to be shifting towards younger people [30] . In countries of Southeast Asia, such as Thailand or Philippines, the large majority of cases occur in children <15 years of age [4, 15, 31] . These patterns could be at least partially explained by the age patters of the population and the high endemicity of dengue in Southeast Asia, where most adults are immune. However, other factors such as genetic resistance to dengue, differences in reporting, and epidemiological surveillance could also help explain observed differences. Any robust conclusions about differences in the 1997 and 2009 guidelines and implications to improve clinical management would require studies conducted in other endemic regions.
Overall, our results suggest there is a substantial degree of agreement between 1997 and 2009 guidelines for dengue classification, and that clinicians should exercise caution when considering the clinical applicability of both guidelines to detect more severe manifestations of dengue. Although our results suggest that the revised guidelines improved the detection of SD, this may not always be the case. While WHO 2009 guidelines represent an improvement for clinicians, mostly due to the identification of patients with warning signs that are likely to progress to SD or even death if there is no early medical care, they do not comprehensively capture the heterogeneity of clinical manifestations and epidemiology of dengue. To improve clinical diagnosis, a prospective international multicentre study could be conducted to assess factors that best predict dengue severity, and add some flexibility to 2009 guidelines, so that they can better adapt to regional epidemiology. We hope that the results presented here further debate about the 1997 and 2009 WHO guidelines, particularly about their clinical value , reduction of study comparability from various disease severity classifications, and can help inform the discussion about ways in which future guidelines could be improved to better support the clinical management of dengue.
